TrialAsian journal of andrology

Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3.

Enzo Vicari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.